BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10858286)

  • 1. A quantitative study of the in vitro binding of the C-terminal domain of p21 to PCNA: affinity, stoichiometry, and thermodynamics.
    Zheleva DI; Zhelev NZ; Fischer PM; Duff SV; Warbrick E; Blake DG; Lane DP
    Biochemistry; 2000 Jun; 39(25):7388-97. PubMed ID: 10858286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction.
    Chen IT; Akamatsu M; Smith ML; Lung FD; Duba D; Roller PP; Fornace AJ; O'Connor PM
    Oncogene; 1996 Feb; 12(3):595-607. PubMed ID: 8637717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigen.
    Warbrick E; Lane DP; Glover DM; Cox LS
    Curr Biol; 1995 Mar; 5(3):275-82. PubMed ID: 7780738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mediation of proliferating cell nuclear antigen (PCNA)-dependent DNA replication through a conserved p21(Cip1)-like PCNA-binding motif present in the third subunit of human DNA polymerase delta.
    Ducoux M; Urbach S; Baldacci G; Hübscher U; Koundrioukoff S; Christensen J; Hughes P
    J Biol Chem; 2001 Dec; 276(52):49258-66. PubMed ID: 11595739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the C-terminal region of p21(WAF1/CIP1) complexed with human PCNA.
    Gulbis JM; Kelman Z; Hurwitz J; O'Donnell M; Kuriyan J
    Cell; 1996 Oct; 87(2):297-306. PubMed ID: 8861913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The C-terminal region of p21SDI1/WAF1/CIP1 is involved in proliferating cell nuclear antigen binding but does not appear to be required for growth inhibition.
    Nakanishi M; Robetorye RS; Pereira-Smith OM; Smith JR
    J Biol Chem; 1995 Jul; 270(29):17060-3. PubMed ID: 7615495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible phosphorylation at the C-terminal regulatory domain of p21(Waf1/Cip1) modulates proliferating cell nuclear antigen binding.
    Scott MT; Morrice N; Ball KL
    J Biol Chem; 2000 Apr; 275(15):11529-37. PubMed ID: 10753973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The DNA repair endonuclease XPG binds to proliferating cell nuclear antigen (PCNA) and shares sequence elements with the PCNA-binding regions of FEN-1 and cyclin-dependent kinase inhibitor p21.
    Gary R; Ludwig DL; Cornelius HL; MacInnes MA; Park MS
    J Biol Chem; 1997 Sep; 272(39):24522-9. PubMed ID: 9305916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 39 amino acid fragment of the cell cycle regulator p21 is sufficient to bind PCNA and partially inhibit DNA replication in vivo.
    Chen J; Peters R; Saha P; Lee P; Theodoras A; Pagano M; Wagner G; Dutta A
    Nucleic Acids Res; 1996 May; 24(9):1727-33. PubMed ID: 8649992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The C-terminal domain of p21 inhibits nucleotide excision repair In vitro and In vivo.
    Cooper MP; Balajee AS; Bohr VA
    Mol Biol Cell; 1999 Jul; 10(7):2119-29. PubMed ID: 10397753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of nucleotide excision repair by the cyclin-dependent kinase inhibitor p21.
    Pan ZQ; Reardon JT; Li L; Flores-Rozas H; Legerski R; Sancar A; Hurwitz J
    J Biol Chem; 1995 Sep; 270(37):22008-16. PubMed ID: 7665622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of the proliferating cell nuclear antigen-interacting domain of p21(CIP1) on DNA synthesis catalyzed by the human and Saccharomyces cerevisiae polymerase delta holoenzymes.
    Gibbs E; Kelman Z; Gulbis JM; O'Donnell M; Kuriyan J; Burgers PM; Hurwitz J
    J Biol Chem; 1997 Jan; 272(4):2373-81. PubMed ID: 8999948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional sites of human PCNA which interact with p21 (Cip1/Waf1), DNA polymerase delta and replication factor C.
    Oku T; Ikeda S; Sasaki H; Fukuda K; Morioka H; Ohtsuka E; Yoshikawa H; Tsurimoto T
    Genes Cells; 1998 Jun; 3(6):357-69. PubMed ID: 9734782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
    Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
    Oncogene; 1999 May; 18(21):3290-302. PubMed ID: 10359535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homologous regions of Fen1 and p21Cip1 compete for binding to the same site on PCNA: a potential mechanism to co-ordinate DNA replication and repair.
    Warbrick E; Lane DP; Glover DM; Cox LS
    Oncogene; 1997 May; 14(19):2313-21. PubMed ID: 9178907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1.
    Chuang LS; Ian HI; Koh TW; Ng HH; Xu G; Li BF
    Science; 1997 Sep; 277(5334):1996-2000. PubMed ID: 9302295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and biochemical studies of human proliferating cell nuclear antigen complexes provide a rationale for cyclin association and inhibitor design.
    Kontopidis G; Wu SY; Zheleva DI; Taylor P; McInnes C; Lane DP; Fischer PM; Walkinshaw MD
    Proc Natl Acad Sci U S A; 2005 Feb; 102(6):1871-6. PubMed ID: 15681588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p21Cip1/Waf1 disrupts the recruitment of human Fen1 by proliferating-cell nuclear antigen into the DNA replication complex.
    Chen U; Chen S; Saha P; Dutta A
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11597-602. PubMed ID: 8876181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Essential interaction between the fission yeast DNA polymerase delta subunit Cdc27 and Pcn1 (PCNA) mediated through a C-terminal p21(Cip1)-like PCNA binding motif.
    Reynolds N; Warbrick E; Fantes PA; MacNeill SA
    EMBO J; 2000 Mar; 19(5):1108-18. PubMed ID: 10698951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p21 Exploits Residue Tyr151 as a Tether for High-Affinity PCNA Binding.
    Kroker AJ; Bruning JB
    Biochemistry; 2015 Jun; 54(22):3483-93. PubMed ID: 25972089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.